| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-05 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.68 | 0.0002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.63 | 0.0003 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |